MIT scientists discover ‘remarkable’ way to reverse Alzheimer’s disease
Scientists at MIT have unlocked a major breakthrough in the battle to reverse the effects of Alzheimer’s disease — one that shows “dramatic reductions” in neurodegeneration, a report stated.
The exciting achievement came about after researchers were able to interfere with an enzyme typically found to be overactive in the brains of Alzheimer’s patients.
The hyperactive enzyme, CDK5, was treated with an unnamed peptide, or string of amino acids.
Early tests conducted on mice revealed significant — and promising — results.
“This peptide has the ability to enter the brain and in a couple of different models, the peptide shows protective effects against loss of neurons and also appears to be able to rescue some of the behavior deficits,” study author Li-Huei Tsai, director of MIT’s Picower Institute for Learning and Memory, told The Post.